The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in African countries

The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday. In 2024,

More than 26,500 mpox cases and 724 deaths have been reported in 15 African countries since the beginning of this year, according to the Africa Centres for Disease Control and Prevention (Africa CDC),

Gavi, the Vaccine Alliance, and Bavarian Nordic today announced an advanced purchase agreement to secure 500,000 doses of Jynneos mpox vaccine for African countries, which will be delivered this year.

The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus.